News & Updates

Low-intensity shockwave with PDE-5i safe, effective for erectile dysfunction

29 Sep 2021

The combination of low-intensity shockwave therapy (Li-ESWT) with phosphodiesterase 5 inhibitor (PDE-5i) medication safely improves erectile function in vasculogenic erectile dysfunction (ED) patients who had failed first-line oral therapy, a recent study has found.

Low-intensity shockwave with PDE-5i safe, effective for erectile dysfunction

29 Sep 2021

Dual therapy confers no survival gains in advanced renal cell carcinoma

23 Sep 2021

Dual therapy with immune checkpoint inhibitors does not appear to prolong overall survival as compared with sunitinib alone for advanced renal cell carcinoma patients with favourable risk, according to the results of a meta-analysis.

Dual therapy confers no survival gains in advanced renal cell carcinoma

23 Sep 2021

Meatotomy insufficient for achieving continence in young girls with ADUS, DUI

17 Sep 2021

Meatal correction shows limited efficacy in young girls with anterior-deflected urinary stream (ADUS) and daytime urinary incontinence (DUI), a new study has found.

Meatotomy insufficient for achieving continence in young girls with ADUS, DUI

17 Sep 2021

Apalutamide plus ADT effective against pain, fatigue in metastatic prostate cancer

16 Sep 2021 by

Treatment with apalutamide plus androgen deprivation therapy (ADT) results in consistently favourable pain scores and less interference from pain in the daily lives of patients with metastatic castration-sensitive prostate cancer compared with placebo plus ADT, results of the phase III TITAN study have shown. Moreover, there was no difference for change seen in fatigue with apalutamide vs placebo.

Apalutamide plus ADT effective against pain, fatigue in metastatic prostate cancer

16 Sep 2021

Pembrolizumab may alter adjuvant treatment landscape of kidney cancer

16 Sep 2021 by

The use of pembrolizumab significantly improved disease-free survival (DFS) in patients with clear-cell renal cell carcinoma (RCC) who have undergone nephrectomy, with or without metastasectomy, and were at high risk for recurrence, according to the phase III KEYNOTE-564 trial.

Pembrolizumab may alter adjuvant treatment landscape of kidney cancer

16 Sep 2021

Benign prostatic hyperplasia on the rise, surgical interventions declining

14 Sep 2021

There seems to be an increasing trend in the diagnosis rate of benign prostatic hyperplasia (BPH), accompanied by a gradual rise in medical treatment and decline in surgical interventions, a new South Korea study has shown.

Benign prostatic hyperplasia on the rise, surgical interventions declining

14 Sep 2021

Urine colour, void number detect underhydration in adults, children

09 Sep 2021

A recent study suggests the utilization of urine colour alone and the combination of urine colour (UC) with void number as a simple field-measure to identify underhydration in adults and children based on elevated urine osmolality (UOsm).

Urine colour, void number detect underhydration in adults, children

09 Sep 2021

Obesity may influence survival in metastatic castration-resistant prostate cancer

08 Sep 2021 by

The obesity paradox, where obesity appears to confer a protective effect, was noted in metastatic castration-resistant prostate cancer (CRPC), with improved survival outcomes among obese patients with metastatic CRPC, according to a study from EAU21.

Obesity may influence survival in metastatic castration-resistant prostate cancer

08 Sep 2021

Outcomes of active surveillance for prostate cancer may vary with age

07 Sep 2021 by

The benefits of active surveillance for prostate cancer appear to be greater in men diagnosed with low-risk prostate cancer at an older age, according to a study from Sweden.

Outcomes of active surveillance for prostate cancer may vary with age

07 Sep 2021

Chronic catheterization may put individuals at risk of bladder cancer

07 Sep 2021 by

Chronic indwelling or intermittent bladder catheterization contributes to an increased risk of bladder cancer and related mortality, with the highest risk observed among individuals using catheters for almost 3 years as well as those with bladder calculi, as suggested in a recent study.

Chronic catheterization may put individuals at risk of bladder cancer

07 Sep 2021

News & Updates

Filter by Specialty:

Specialty:

Low-intensity shockwave with PDE-5i safe, effective for erectile dysfunction

Low-intensity shockwave with PDE-5i safe, effective for erectile dysfunction

Dual therapy confers no survival gains in advanced renal cell carcinoma

Dual therapy confers no survival gains in advanced renal cell carcinoma

Meatotomy insufficient for achieving continence in young girls with ADUS, DUI

Meatotomy insufficient for achieving continence in young girls with ADUS, DUI

Apalutamide plus ADT effective against pain, fatigue in metastatic prostate cancer

Apalutamide plus ADT effective against pain, fatigue in metastatic prostate cancer

Pembrolizumab may alter adjuvant treatment landscape of kidney cancer

Pembrolizumab may alter adjuvant treatment landscape of kidney cancer

Benign prostatic hyperplasia on the rise, surgical interventions declining

Benign prostatic hyperplasia on the rise, surgical interventions declining

Urine colour, void number detect underhydration in adults, children

Urine colour, void number detect underhydration in adults, children

Obesity may influence survival in metastatic castration-resistant prostate cancer

Obesity may influence survival in metastatic castration-resistant prostate cancer

Outcomes of active surveillance for prostate cancer may vary with age

Outcomes of active surveillance for prostate cancer may vary with age

Chronic catheterization may put individuals at risk of bladder cancer

Chronic catheterization may put individuals at risk of bladder cancer